Skip to main content
Investigative Journalism Foundation
Lobbying

Lobby Roundup: AstraZeneca lobbying on drug pricing nationwide after Liberals backtrack on promise to cut pharmaceutical prices

And eight other insights from the IJF’s weekly lobbying roundup

Xavier Richer Vis

18 May 2023 4 min read

Copied to clipboard!
Article feature image
Prime Minister Justin Trudeau answers questions at an event where AstraZeneca announced the company would be making a $500-million investment in Canada and adding up to 500 new jobs at its Mississauga, Ontario. (The Canadian Press//Frank Gunn)

Xavier Richer Vis
Xavier Richer Vis

Xavier is a Toronto-based journalist and a graduate of Goldsmiths, University of London’s master’s in digital journalism. He first joined the IJF as a data-scraping volunteer. His work has appeared in Wired.

Dig Deeper

Our databases turn public records into public power. Dig in to find the real story on lobbying, donations, contracts, access to information releases and more.

Search

Related Articles